Boehringer Ingelheim ToMORROW Mastitis Treatment (RX Only)

Out of stock

SKU:
U3044162
Model Number:
304162
Brand/Manufacturer:
Boehringer Ingelheim
$2.99
/ EA
ToMORROW® gives dairy producers time tested, board-spectrum control against the harmful organisms that cause mastitis in dry cows.
Compositions
: Peanut oil, Aluminum Stearate, Cephapirin Benzathine
Form
: Liquid
Color
: White/Yellow
Container Type
: Pail
Flash Point
: 541.4 deg F
  • ToMORROW® has been an effective prolonged therapy treatment for more than 25 years and studies have shown no change in the development of bacterial resistance
  • ToMORROW® has been shown by extensive clinical studies to be efficacious in the treatment of mastitis in dry cows when caused by streptococcus agalactiae and staphylococcus aureus including penicillin-resistant stains
  • ToMORROW® is formulated with cephapirin benzathine to provide broad spectrum and long-acting therapy that dry cows need
  • Shorter milk withhold 72 hr after calving versus 96 hr for quartermaster means you can put your cows back into production sooner after calving
  • Shorter slaughter withhold 42 days after last infusion with ToMORROW® treatment compared to 60 days for quartermaster allows you to move 18 days faster
  • ToMORROW® treatment effectively controls Gram-positive organisms, which represent 94% of infections that occur during dry-off
  • Increases convenience and reduces the risk of new infections The Opti-Sert® tip reduces new mastitis infections by up to 50% and makes partial insertion much easier
StoreAvailabilityPhoneDistance